Latest HTA updates for myeloma and AL amyloidosis: Summer 2023
New treatment appraisals continue to come through the Health Technology Appraisal (HTA) pipeline.
Myeloma UK is involved in seven active appraisals between the National Institute for Healthcare Excellence (NICE) and the Scottish Medicines Consortium (SMC).